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Purpose
Merkel cell carcinoma (MCC) is a highly aggressive skin
cancer with strong evidence for viral carcinogenesis. The
association of MCC with the Merkel cell polyomavirus
(MCPyV) may explain the explicit immunogenicity of
MCC. Indeed, MCPyV-encoded proteins are likely targets
for cytotoxic immune responses to MCC as they are both
foreign to the host and necessary to maintain the onco-
genic phenotype. However, to date only a single MCPyV-
derived CD8 T-cell epitope have been described, thus
impeding specific monitoring of T-cell responses to MCC.
Method
To overcome this limitation, we scanned the MCPyV
oncoproteins large T and small T antigen and the virus-
capsid protein VP1 for potential T-cell epitopes, and
tested for major histocompatibility complex (MHC) class I
affinity. We confirmed the relevance of these epitopes
using a high-throughput platform for T-cell enrichment
and combinatorial encoding of MHC class I multimers.
Results
In peripheral blood from 38 MCC patients and 30
healthy donors we identified 53 MCPyV-directed CD8+
T-cell responses against 35 different peptide sequences.
Strikingly, T-cell responses against oncoproteins were
exclusively present in MCC patients, but not in healthy
donors. We further demonstrate both the processing and
presentation of the oncoprotein-derived epitopes, as well
as the lytic activity of oncoprotein-specific T cells
towards MHC-matched MCC cells. Demonstrating the
presence of oncoprotein-specific T cells among tumour
infiltrating lymphocytes ex vivo further substantiated the
relevance of the identified epitopes.
Conclusion
These T-cell epitopes represent ideal targets for antigen
specific immune therapy of MCC, and enables tracking
and characterisation of MCPyV specific immune responses.
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